Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis
出版年份 2019 全文链接
标题
Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis
作者
关键词
-
出版物
CNS DRUGS
Volume 33, Issue 6, Pages 549-566
出版商
Springer Science and Business Media LLC
发表日期
2019-05-08
DOI
10.1007/s40263-019-00625-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder
- (2018) Armin Szegedi et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Assessment and Treatment of Antipsychotic-Induced Akathisia
- (2018) Tamara Pringsheim et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies
- (2018) Katharina Stegmayer et al. CNS DRUGS
- Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study
- (2018) Mary Hobart et al. CURRENT MEDICAL RESEARCH AND OPINION
- A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia
- (2018) Andy Forbes et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study
- (2018) Terence A. Ketter et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy of adjunctive brexpiprazole on the core symptoms of major depressive disorder: A post hoc analysis of two pooled clinical studies
- (2018) J. Craig Nelson et al. JOURNAL OF AFFECTIVE DISORDERS
- Short-term efficacy and tolerability of lurasidone in the treatment of acute schizophrenia: A meta-analysis of randomized controlled trials
- (2018) Wei Zheng et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Tardive syndromes
- (2018) Daniel Savitt et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Long-term safety and effectiveness of brexpiprazole in Japanese patients with schizophrenia: A 52-week, open-label study
- (2018) Jun Ishigooka et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Efficacy and safety of brexpiprazole for the treatment of acute schizophrenia in Japan: A 6-week, randomized, double-blind, placebo-controlled study
- (2018) Jun Ishigooka et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Long-term effects of iloperidone on cerebral dopamine receptor subtypes
- (2018) Yong Kee Choi et al. SYNAPSE
- Long-Term Effects of Iloperidone on Cerebral Serotonin and Adrenoceptor Subtypes
- (2018) Yong Kee Choi et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia
- (2017) Willie Earley et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Tolerability of cariprazine in the treatment of acute bipolar I mania: A pooled post hoc analysis of 3 phase II/III studies
- (2017) Willie Earley et al. JOURNAL OF AFFECTIVE DISORDERS
- Adjunctive Brexpiprazole as a Novel Effective Strategy for Treating Major Depressive Disorder
- (2017) Seoyoung Yoon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Activating and Sedating Adverse Effects of Second-Generation Antipsychotics in the Treatment of Schizophrenia and Major Depressive Disorder
- (2017) Leslie Citrome JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
- (2017) György Németh et al. LANCET
- Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment
- (2017) Maria Juncal-Ruiz et al. PSYCHOPHARMACOLOGY
- Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews
- (2017) Michele Fornaro et al. Biomed Research International
- Clinical role of brexpiprazole in depression and schizophrenia
- (2017) Nishant Parikh et al. Therapeutics and Clinical Risk Management
- Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review
- (2017) Marco Solmi et al. Therapeutics and Clinical Risk Management
- Rapid vs. slow antipsychotic initiation in schizophrenia: A systematic review and meta-analysis
- (2017) Hiroyoshi Takeuchi et al. SCHIZOPHRENIA RESEARCH
- Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies
- (2016) Stephen R. Marder et al. ACTA NEUROPSYCHIATRICA
- Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study
- (2016) Trisha Suppes et al. AMERICAN JOURNAL OF PSYCHIATRY
- An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression
- (2016) Suresh Durgam et al. AMERICAN JOURNAL OF PSYCHIATRY
- Brexpiprazole
- (2016) Marija Markovic et al. ANNALS OF PHARMACOTHERAPY
- Asenapine: A Review in Schizophrenia
- (2016) Greg L. Plosker et al. CNS DRUGS
- Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials
- (2016) Kim S. J. Lao et al. CNS DRUGS
- A Randomized Trial of Iloperidone for Prevention of Relapse in Schizophrenia: The REPRIEVE Study
- (2016) Peter J. Weiden et al. CNS DRUGS
- Asenapine for the treatment of adults with an acute exacerbation of schizophrenia: results from a randomized, double-blind, fixed-dose, placebo-controlled trial with olanzapine as an active control
- (2016) Ronald Landbloom et al. CNS SPECTRUMS
- Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study
- (2016) Christoph U. Correll et al. CNS SPECTRUMS
- The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia
- (2016) Leslie Citrome et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Cariprazine in the treatment of schizophrenia
- (2016) Suresh Durgam et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Acute movement disorders in the medical setting
- (2016) Ifrah Zawar et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
- Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: Results from a post-hoc analysis of two randomised controlled trials
- (2016) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Asenapine: Efficacy and safety of 5 and 10 mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder
- (2016) Ronald L. Landbloom et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants
- (2016) Suresh Durgam et al. JOURNAL OF CLINICAL PSYCHIATRY
- Lurasidone Dose Escalation in Early Nonresponding Patients With Schizophrenia
- (2016) Antony Loebel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts
- (2016) Trisha Suppes et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Cariprazine for the Treatment of Bipolar Disorder
- (2016) Lillian Jan Findlay et al. PERSPECTIVES IN PSYCHIATRIC CARE
- Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile
- (2016) Rafał R. Jaeschke et al. Pharmacological Reports
- Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre, randomized, double-blind, 6-week, placebo-controlled study
- (2016) Toshihiko Kinoshita et al. PSYCHOPHARMACOLOGY
- Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study
- (2016) Suresh Durgam et al. PSYCHOPHARMACOLOGY
- Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia
- (2016) John M. Kane et al. SCHIZOPHRENIA RESEARCH
- Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies
- (2016) Christoph U. Correll et al. SCHIZOPHRENIA RESEARCH
- Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial
- (2016) Suresh Durgam et al. SCHIZOPHRENIA RESEARCH
- Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies
- (2016) Stephen R. Marder et al. ACTA NEUROPSYCHIATRICA
- Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial
- (2015) Christoph U. Correll et al. AMERICAN JOURNAL OF PSYCHIATRY
- Akathisia With Azithromycin
- (2015) Amber Riesselman et al. ANNALS OF PHARMACOTHERAPY
- Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation
- (2015) Antony Loebel et al. BMC Psychiatry
- Lurasidone: A Review of Its Use in Adult Patients with Bipolar I Depression
- (2015) Mark Sanford et al. CNS DRUGS
- The clinical challenges of akathisia
- (2015) James B. Lohr et al. CNS SPECTRUMS
- The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis
- (2015) Jennifer E. Thomas et al. Current Neuropharmacology
- P.3.d.072 Efficacy and safety of brexpiprazole (OPC-34712) in acute schizophrenia: a pooled analysis of two pivotal studies
- (2015) C. Correli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cariprazine in the treatment of acute mania in bipolar I disorder: A double-blind, placebo-controlled, Phase III trial
- (2015) Gary S. Sachs et al. JOURNAL OF AFFECTIVE DISORDERS
- Lurasidone in the Treatment of Bipolar Depression With Mixed (Subsyndromal Hypomanic) Features
- (2015) Roger S. McIntyre et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effects of Asenapine in Bipolar I Patients Meeting Proxy Criteria for Moderate-to-Severe Mixed Major Depressive Episodes
- (2015) Michael Berk et al. JOURNAL OF CLINICAL PSYCHIATRY
- Cariprazine in Acute Exacerbation of Schizophrenia
- (2015) Suresh Durgam et al. JOURNAL OF CLINICAL PSYCHIATRY
- Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants
- (2015) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder
- (2015) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHIATRY
- A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia
- (2015) John M. Kane et al. SCHIZOPHRENIA RESEARCH
- Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset
- (2015) F. Berna et al. SCHIZOPHRENIA RESEARCH
- The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial
- (2014) Suresh Durgam et al. BIPOLAR DISORDERS
- Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies
- (2014) Henry A. Nasrallah et al. CNS SPECTRUMS
- Balancing benefits and harms of treatments for acute bipolar depression
- (2014) Terence A. Ketter et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy and Safety of Low- and High-Dose Cariprazine in Acute and Mixed Mania Associated With Bipolar I Disorder
- (2014) Joseph R. Calabrese et al. JOURNAL OF CLINICAL PSYCHIATRY
- An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial
- (2014) Suresh Durgam et al. SCHIZOPHRENIA RESEARCH
- A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia
- (2014) Peter J. Weiden et al. SCHIZOPHRENIA RESEARCH
- Cariprazine in Schizophrenia: Clinical Efficacy, Tolerability, and Place in Therapy
- (2013) Leslie Citrome ADVANCES IN THERAPY
- Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
- (2013) Antony Loebel et al. AMERICAN JOURNAL OF PSYCHIATRY
- Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
- (2013) Antony Loebel et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Review of the Pharmacology, Efficacy and Tolerability of Recently Approved and Upcoming Oral Antipsychotics: An Evidence-Based Medicine Approach
- (2013) Leslie Citrome CNS DRUGS
- Role of α1 adrenergic antagonism in the mechanism of action of iloperidone: reducing extrapyramidal symptoms
- (2013) Stephen M. Stahl CNS SPECTRUMS
- Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial
- (2013) Andrew J. Cutler et al. CNS SPECTRUMS
- Newer antipsychotics and upcoming molecules for schizophrenia
- (2013) Melvin George et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability
- (2013) Leslie Citrome Expert Opinion on Drug Metabolism & Toxicology
- Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed
- (2013) Leslie Citrome et al. JOURNAL OF AFFECTIVE DISORDERS
- Effectiveness of Lurasidone for Patients With Schizophrenia Following 6 Weeks of Acute Treatment With Lurasidone, Olanzapine, or Placebo
- (2013) Stephen M. Stahl et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effectiveness of Lurasidone in Patients with Schizophrenia or Schizoaffective Disorder Switched From Other Antipsychotics
- (2013) Joseph P. McEvoy et al. JOURNAL OF CLINICAL PSYCHIATRY
- Estimating Dopamine D2 Receptor Occupancy for Doses of 8 Antipsychotics
- (2013) Irene M. Lako et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Tardive dystonic syndrome induced by the calcium-channel blocker amlodipine
- (2013) Dirk Dressler JOURNAL OF NEURAL TRANSMISSION
- Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study
- (2013) Henry A. Nasrallah et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Efficacy and safety of lurasidone 80mg/day and 160mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial
- (2013) Antony Loebel et al. SCHIZOPHRENIA RESEARCH
- Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study
- (2013) Antony Loebel et al. SCHIZOPHRENIA RESEARCH
- A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia
- (2013) Silvio Caccia et al. Therapeutics and Clinical Risk Management
- The Mechanism of Drug-induced Akathisia
- (2012) Anton J.M. Loonen et al. CNS SPECTRUMS
- Long-term safety and tolerability of lurasidone in schizophrenia
- (2012) Leslie Citrome et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis
- (2012) Jian-Ping Zhang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: Results from post hoc analyses
- (2012) J.M. Azorin et al. JOURNAL OF AFFECTIVE DISORDERS
- A Thorough QTc Study of 3 Doses of Iloperidone Including Metabolic Inhibition Via CYP2D6 and/or CYP3A4 and a Comparison to Quetiapine and Ziprasidone
- (2012) Steven G. Potkin et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The role of striatal dopamine D2 receptors in the occurrence of extrapyramidal side effects: Iodine-123-iodobenzamide single photon emission computed tomography study
- (2012) Iluminada Corripio et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study
- (2012) Masaaki Ogasa et al. PSYCHOPHARMACOLOGY
- Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study
- (2011) Herbert Y. Meltzer et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials
- (2011) Leslie Citrome et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment
- (2011) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Asenapine Versus Olanzapine in People With Persistent Negative Symptoms of Schizophrenia
- (2011) Robert W. Buchanan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Asenapine as Adjunctive Treatment for Acute Mania Associated With Bipolar Disorder
- (2011) Armin Szegedi et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head–head comparisons
- (2011) Peter M Haddad et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder
- (2011) Steven G. Potkin et al. SCHIZOPHRENIA RESEARCH
- The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder
- (2011) Maurizio Pompili et al. Neuropsychiatric Disease and Treatment
- Asenapine: A Review of Acute and Extension Phase Data in Bipolar Disorder
- (2010) Roger S. McIntyre CNS Neuroscience & Therapeutics
- Asenapine for long-term treatment of bipolar disorder: A double-blind 40-week extension study
- (2010) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Asenapine in the treatment of acute mania in bipolar I disorder: A randomized, double-blind, placebo-controlled trial
- (2010) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- New Antipsychotic Drugs: How Do Their Receptor-Binding Profiles Compare?
- (2010) Elliott Richelson JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Asenapine in a Placebo- and Haloperidol-Controlled Trial in Patients With Acute Exacerbation of Schizophrenia
- (2010) John M. Kane et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Movement Disorders Induced by Antipsychotic Drugs: Implications of the CATIE Schizophrenia Trial
- (2010) Stanley N. Caroff et al. NEUROLOGIC CLINICS
- Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder
- (2010) J. Schoemaker et al. PHARMACOPSYCHIATRY
- Adjunctive Aripiprazole, Olanzapine, or Quetiapine for Major Depressive Disorder: An Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
- (2010) Leslie Citrome POSTGRADUATE MEDICINE
- Second-Generation Antipsychotic Drugs and Extrapyramidal Side Effects: A Systematic Review and Meta-analysis of Head-to-Head Comparisons
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA BULLETIN
- Asenapine versus olanzapine in acute mania: a double-blind extension study
- (2009) Roger S McIntyre et al. BIPOLAR DISORDERS
- A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states
- (2009) Roger S McIntyre et al. BIPOLAR DISORDERS
- Lurasidone in the Treatment of Acute Schizophrenia
- (2009) Mitsutaka Nakamura et al. JOURNAL OF CLINICAL PSYCHIATRY
- Akathisia: An Updated Review Focusing on Second-Generation Antipsychotics
- (2009) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Aripiprazole Monotherapy in Nonpsychotic Bipolar I Depression
- (2009) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Antipsychotic-Induced Extrapyramidal Side Effects in Bipolar Disorder and Schizophrenia
- (2009) Keming Gao et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials
- (2009) John M Kane et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Ethnic Differences in the Risks of Adverse Reactions to Drugs Used in the Treatment of Psychoses and Depression
- (2008) Sara Ormerod et al. DRUG SAFETY
- Four-Week, Double-Blind, Placebo- and Ziprasidone-Controlled Trial of Iloperidone in Patients With Acute Exacerbations of Schizophrenia
- (2008) Andrew J. Cutler et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Long-Term Efficacy and Safety of Iloperidone
- (2008) John M. Kane et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Safety Profile of Iloperidone
- (2008) Peter J. Weiden et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Efficacy of Iloperidone in the Treatment of Schizophrenia
- (2008) Steven G. Potkin et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started